Pediatric Acute Leukemia (PedAL) Screening Trial Developing New Therapies for Relapsed Leukemias
- Sponsor:
- COG
- Sponsor Study ID:
- APAL2020SC
- CTO #:
- 103598
- NCT Number:
- NCT04726241
- Phase:
- N/A
- Protocol Type:
- Screening
- Age Group:
- Both
- Disease Sites:
- Myeloid and Monocytic Leukemia
- Study Objectives:
- To utilize clinical and biological characteristics of acute leukemias to screen for patient eligibility for available Phase I/II PedAL sub-trials. To maintain a longitudinal and comprehensive registry from relapse in children and young adults with recurrent and refractory leukemia.
- eConsent:
- Not available
- Study Documents:
-
Open Study Documents
(MUSC NetID required for document access)
For more information about this trial please contact the study team:
-
Medical University of South Carolina
- Principal Investigator, Kraveka, Jacqueline, at kravekjm@musc.edu .
- Study Coordinator, Schaefer, Matthew, at schaefma@musc.edu .
Trial opened at the following institutions:
Medical University of South Carolina